Therefore, radiomics in combination with dynamic detection of Ki-67 and CK-19 expression is useful for timely assessment of HCC progression, and has important clinical implications in early HCC intervention and expansion of the treatment window for patients. The gene discussed is KRT19; the disease is hepatocellular carcinoma.